BioNTech SE
Biotechnology company · Mainz, Rheinland-Pfalz, Germany · Nasdaq: BNTX
BioNTech SE is a biotechnology company headquartered in Mainz, Rheinland-Pfalz, Germany. Its shares trade on Nasdaq under the ticker BNTX. It has reported private securities offerings to the US SEC, most recently $150 million sold in a notice filed in 2022.
BioNTech SE at a glance
What does BioNTech SE do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $150 million sold (2022).
Frequently asked questions about BioNTech SE
Where is BioNTech SE headquartered?
BioNTech SE is headquartered in Mainz, Rheinland-Pfalz, Germany.
What does BioNTech SE do?
BioNTech SE is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is BioNTech SE a public company?
Yes. BioNTech SE trades on Nasdaq under the ticker BNTX.
Similar companies
- Technolas Perfect Vision GmbHMunich, Bavaria, Germany
- Merz AestheticsDessau, Saxony-Anhalt, Germany
- Biofrontera Bioscience GmbHLeverkusen, North Rhine-Westphalia, Germany
- Immatics N.V.Tübingen, Baden-Wurttemberg, Germany
- Gelita AgEberbach, Baden-Wurttemberg, Germany
- HWI pharma services GmbHRülzheim, Rheinland-Pfalz, Germany
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences